Home Forums Melanoma: Stage III Have you progressed on Zelboraf or Dabrafenib?

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #21007
    PatW
    Participant

    A new Phase II clinical trial just opened up for people who have progressed on a BRAF inhibitor. Several sites on the East coast and Tennnessee.

    Clinical Trial Identifier: NCT01519427

    Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib

Viewing 1 post (of 1 total)
  • The forum ‘Melanoma: Stage III’ is closed to new topics and replies.